Robert Marcus
JPMorgan Chase & Co, Research Division
Good afternoon, everyone. I’m Robbie Marcus, med tech analyst at JPMorgan. Very happy to introduce our next company, Penumbra. Adam Elsesser, the CEO, will give a presentation, and then we’ll do some Q&A. Adam?
Adam Elsesser
Co-Founder, Chairman & CEO
Thank you, Robbie, and of course, JPMorgan for hosting us. Robbie was reminding me, I think this is our 10th or 11th time since we went public. So it’s great to be here and a pleasure to talk. Let’s see. Here’s our safe harbor.
Just a quick sort of overview. Our company was started in 2004. So over 20 years ago, we’re headquartered here in the Bay Area in the town of Alameda, which is right across the Bay in the East Bay, a beautiful community.
We have over — a little over 4,500 employees worldwide. All of our products today are manufactured in California. That’s going to change. I’ll get to that in a minute.
And we’ve been around a long time. We have — our products are available in over 100 markets throughout the world.
On the manufacturing front, I wanted to just sort of touch on this because I think it’s important. In Alameda, we have 9 buildings total and obviously, a lot more square footage than this, but 260,000 square feet of it is dedicated to manufacturing here in Alameda.
I think it’s important to point out why that’s what we do that and what the benefit of that is. We are known for iterating our products a lot. We’re quite innovative. We
